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Neuroinflammation is the response of the central nervous system (CNS) to elements that 
interfere with tissue homeostasis and represents a common denominator in virtually all 
neurological diseases. The main reactive cellular components of the CNS include mast cells, 
microglia, astrocytes, and possibly oligodendrocytes (Skaper et al., 2017). Microglia, the 
resident myeloid cells of the CNS, are not only responsible for maintaining immune homeostasis, 
but are also indispensable for CNS development and neuronal cell activity (Casano and Peri, 
2015; Prinz and Priller, 2017). In recent years, increasing evidence has highlighted the crucial 
role of microglial cells in brain development, and several studies have explored how these cells 
participate in shaping the developing CNS. In this context, perturbations or hyperactivation of 
microglia due to pre- or postnatal infections or non-infectious pro-inflammatory conditions may 
negatively affect developing neural circuits and increase the risk of neurodevelopmental 
disorders characterized by cognitive disability, and social and behavioral deficits (Sominsky et 
al., 2018). This special issue collects both reviews and original research articles that seek to 
describe how neuroinflammation, microglia and cytokine abnormalities influence brain 
development and the etiology of neurodevelopmental disorders. 
Guidolin et al provide an overview of the role of cytokines and their signaling pathways in the 
organogenesis of the CNS. Developmental processes underlying the genesis of the CNS are 
regulated by transcription factors as well as by extracellular signals, including cell-cell 
interaction and signals provided by the extracellular matrix. Among extracellular signals, 
cytokines, mostly produced by microglia, play a significant role at all stages of CNS 
development, including induction of neuroepithelium, proliferation and self-renewal of neural 
progenitor cells, generation of morphogenic gradients and regulation of the synaptic pool. 
Perturbation of cytokine production, for example as a consequence of maternal infections, 
environmental factors (e.g., pesticides, air pollutants, dietary components), or prenatal hypoxia 
can significantly impact fetal brain development. Thus, a better knowledge of the cytokine 
imbalance underlying neurodevelopmental disorders is critical for prevention and, possibly, 
treatment of these diseases. 
Microglia have essential roles in intricate and multi-step processes during brain development. 
Konishi et al provide a comprehensive review of the ‘bidirectional’ roles of microglia during 
normal CNS development. Microglia, distributed throughout the brain parenchyma during 
development, participate in various neuronal developmental events, including phagocytosis of 
apoptotic cells and excess newborn neurons, supporting neurogenesis, cell migration, axonal 
growth, synapse formation and remodeling, and mediating cell death and survival (Tay et al., 
2017). Microglia exert dual functions during each of these events by eliminating unnecessary 
cells, axons, and synapses, and supporting the neighboring ones, and by promoting phagocytosis 
and secretion of a variety of molecules, to form refined neural circuits. Understanding the 
molecular mechanisms involved in these processes is essential for preventing developmental 
brain disorders caused by microglia dysfunctions. 
Arcuri et al discuss the role of parenchymal and non-parenchymal immune cells in regulating 
CNS functions. Parenchymal resident immune cells, namely microglia and mast cells, monitor 
CNS parenchyma and perform important physiological functions autonomously from the 
periphery, but they are also capable of becoming activated in pathological conditions. In 
particular, microglia regulate synaptic pruning, neuronal survival and neurogenesis; mast cells, 
positioned near the hippocampus, influence neuronal activities through the secretion of 
numerous neuromodulators (e.g., serotonin) and other molecules (e.g., histamine, cytokines) that 
affect memory, anxiety, learning and neurogenesis. Non-parenchymal immune cells, located at 
the CNS border, in subarachnoid space, choroid plexus and lymphatic vessels, are sensitive to 
external stimuli and influence parenchymal immune cells by secreted factors or by direct 
interactions. The two systems can interact with each other, but the extent of this cross-talk 
remains unclear. 
Recent evidence indicates a critical role for microglia and astrocytes in oligodendrogenesis, 
mediated by the production of cytokines, growth factors and other components important to 
drive oligodendrocyte differentiation and maturation (Miron, 2017). Understanding the complex 
immune cell-oligodendrocyte interaction can increase our knowledge of diseases caused by 
incomplete or erroneous myelination. Gingele et al investigate how microglia of different 
activation states (i.e., M0, M1, and M2-like subtypes) influence oligodendrocyte lineage cells 
indirectly via astrocytes. Authors analyze growth factor expression in astrocytes and the effect 
on proliferation, differentiation, and migration of oligodendrocyte precursor cells (OPCs). They 
show that treatment of astrocytes with supernatants from pro-inflammatory M1-like microglia 
results in upregulation of gene transcripts of growth factors which predominantly induce OPC 
proliferation, differentiation, and survival and are crucial for remyelination. In contrast, M0- and 
M2-like microglia have only marginal effects on gene expression of these factors in astrocytes. 
This suggests that M2-like microglia are unlikely to exert remyelination supportive effects 
indirectly via astrocytes, but rather via direct effects on OPCs. 
Recent studies indicate that mitochondrial functions, glucose availability and glycolytic rate 
influence microglia activation and neuroinflammation (Ghosh et al., 2018). Saito et al examine 
the literature surrounding the possible role that adenosine monophosphate-activated protein 
kinase (AMPK), which regulates energy homeostasis, could have in the regulation of energy 
balance of microglia during neuroinflammation and neurodegeneration in the developing as well 
as mature CNS. In this context, the authors consider this molecule as a candidate for regulation 
of pro- and anti-inflammatory microglia responses. 
The developing brain in the perinatal period is highly vulnerable and extremely sensitive to 
inflammatory challenges of infectious and non-infectious nature that can affect immune cell 
functions. In this context, accumulating evidence shows that maternal obesity, metabolic 
disorders, and high-fat diet induce a chronic low-grade inflammation, which is associated with 
adverse offspring health and neurodevelopmental outcomes (Bilbo and Tsang, 2010; Kang et al., 
2014). Edlow et al examine a novel concept about the similarity in immune response between 
placental macrophages and brain microglia. Authors isolate CD11b
+
 microglia and placental 
cells from embryos of lean and obese mouse dams. They demonstrate that maternal obesity 
primes CD11b
+
 microglia and placental macrophages to overproduce the pro-inflammatory 
cytokine TNF-α in response to lipopolysaccharide stimulation. This effect is most pronounced in 
male fetal microglia and placental macrophages, suggesting the male predominance of certain 
neurodevelopmental disorders linked to maternal obesity (e.g., cognitive disfunction, autism 
spectrum disorder and ADHD).  
In uncomplicated pregnancy there is a normal systemic inflammatory response, which becomes 
exaggerated in pregnancy complications, such as pre-eclampsia (Redman and Sargent, 2003). 
While the adverse effect of pre-eclampsia on maternal and fetal health is recognized, the long-
term impact of this condition on the risk of neurodevelopmental disorders, such as autism 
spectrum disorder, in exposed offspring is a topic of debate. Maher et al present a comprehensive 
review examining recent evidence suggesting a relationship between maternal pre-eclampsia-
induced inflammation and neurological outcomes in offspring. Data analyzed support the idea 
that fetal exposure to pre-eclampsia-induced maternal inflammation may increase the risk of 
neurodevelopmental disorders and perhaps also the risk of these disorders in genetically 
predisposed offspring. Furthermore, the authors raise an important unaddressed question about 
the potential impact of antihypertensive pharmacological treatments during pregnancy on the 
observed association. 
Nguyen et al present a narrative review that integrates clinical and preclinical studies focusing 
on punctate white matter lesions in neonates, a specific form of focal non-cystic white matter 
injury, detected by high resolution MRI. These focal lesions, frequently detected in the preterm 
and full-term infants, may result from inflammatory or ischemic processes or from 
neuroinflammation following pre and/or postnatal infections. These lesions are characterized by 
loss of astrocytes and neurofilaments, neuronal amyloid precursor protein accumulation, and a 
dense accumulation of activated microglia, and in preterm infants can be associated with 
neurodevelopment disorders. The authors highlight the importance of imaging techniques to 
screen brain lesions in critically-ill infants, considering that, in some cases, these may determine 
their prognosis and outcome. 
During adolescence the immature brain is extremely vulnerable to the effects of alcohol and 
other drug abuse (Winters et al., 2012). Ethanol consumption in adolescence affects brain 
plasticity and causes structural and functional changes in immature brain areas (prefrontal cortex 
and limbic system) that result in cognitive and behavioral deficits (Pascual et al., 2018). Guerri 
et al review the action of alcohol and drug abuse (cannabis, cocaine, opioids, amphetamines, 
anabolic androgenic steroids) in the adolescent brain and focus on the impact on both cognition 
and behavioral dysfunction, including predisposition to drug abuse in later life. Authors also 
describe the molecular and cellular mechanisms at the basis of neuroimmune dysfunction due to 
alcohol and drug abuse in adolescence, suggesting the therapeutic potential of anti-inflammatory 
targets to prevent the long-term consequences of drug abuse. 
In summary, this special issue will include both literature reviews and original research articles 
on the state of our knowledge of the mechanisms by which neuroinflammation and microglia 
influence brain development in both healthy and pathological contexts. Moreover, it will 
highlight the impact of a dysregulated immune response in the etiology of neurodevelopmental 
alterations. 
 
 
References 
 
Bilbo, S.D., Tsang, V., 2010. Enduring consequences of maternal obesity for brain inflammation 
and behavior of offspring. FASEB J. 24, 2104-2115. 
Casano, A.M., Peri, F., 2015. Microglia: multitasking specialists of the brain. Dev. Cell 32, 469-
477. 
Ghosh, S., Castillo, E., Frias, E.S., Swanson, R.A., 2018. Bioenergetic regulation of microglia. 
Glia 66, 1200-1212. 
Kang, S.S., Kurti, A., Fair, D.A., Fryer, J.D., 2014. Dietary intervention rescues maternal obesity 
induced behavior deficits and neuroinflammation in offspring. J. Neuroinflammation 11, 156. 
Miron, V.E., 2017. Microglia-driven regulation of oligodendrocyte lineage cells, myelination, 
and remyelination. J. Leukoc. Biol. 101, 1103-1108. 
Pascual, M., Montesinos, J., Guerri, C., 2018.  Role of the innate immune system in the 
neuropathological consequences induced by adolescent binge drinking. J. Neurosci. Res. 96, 
765-780.  
Prinz, M., Priller, J., 2017. The role of peripheral immune cells in the CNS in steady state and 
disease. Nat. Neurosci. 20, 136-144. 
Redman, C.W., Sargent, I.L., 2003. Pre-eclampsia, the placenta and the maternal systemic 
inflammatory response–a review. Placenta 24 (Suppl A), S21-27. 
Skaper, S.D., Facci, L., Zusso, M., Giusti, P., 2017. Neuroinflammation, Mast Cells, and Glia: 
Dangerous Liaisons. Neuroscientist 23, 478-498.  
Sominsky, L., De Luca, S., Spencer, S.J., 2018. Microglia: Key players in neurodevelopment and 
neuronal plasticity. Int. J. Biochem. Cell Biol. 94, 56-60.  
Tay, T.L., Savage, J.C., Hui, C.W., Bisht, K., Tremblay, M.E., 2017. Microglia across the 
lifespan: from origin to function in brain development, plasticity and cognition. J. Physiol. 595, 
1929-1945. 
Winters, K.C., Fahnhorst, T., Botzet, A., Lee, S., Lalone, B., 2012. Brief intervention for drug-
abusing adolescents in a school setting: outcomes and mediating factors. J. Subst. Abuse Treat. 
42, 279-288. 
